Valeo Pharma Inc. Stock Canadian Securities Exchange
Stocks
VPH
CA91915B1085
Pharmaceuticals
OTC Markets Traded|
Delayed
Canadian Securities Exchange
15:57:37 2022-03-28 EDT
|
5-day change | 1st Jan Change | ||
| 0.6600 CAD | -.--% |
|
+1.54% | -10.81% |
| Market Cap | 6.24M 4.45M 3.88M 3.67M 3.33M 427M 6.26M 43.92M 16.95M 217M 16.73M 16.36M 699M | P/E 2022 |
-2.09x | P/E 2023 | -0.45x |
|---|---|---|---|---|---|
| Enterprise Value | 64.5M 46.04M 40.15M 37.91M 34.42M 4.42B 64.77M 454M 175M 2.25B 173M 169M 7.23B | EV / Sales 2022 |
3.37x | EV / Sales 2023 | 1.35x |
| Free-Float |
52.66% | Yield 2022 * |
-
| Yield 2023 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Steven Saviuk
CEO | Chief Executive Officer | 67 | 2003-03-26 |
Pascal Tougas
DFI | Director of Finance/CFO | - | 2023-11-19 |
Frédéric Dumais
IRC | Investor Relations Contact | - | 2019-05-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Steven Saviuk
CHM | Chairman | 67 | 2024-08-05 |
Richard MacKay
CHM | Chairman | 91 | 2018-07-24 |
Marc Léger
BRD | Director/Board Member | 67 | 2022-04-26 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | +1.54% | - | - | 98 | |
| +0.04% | +3.34% | +53.32% | +100.52% | 1,028B | |
| -0.09% | +1.66% | +53.24% | +66.45% | 651B | |
| -0.02% | +2.66% | +18.65% | +71.97% | 466B | |
| -1.22% | +3.66% | +34.59% | +38.81% | 346B | |
| -0.79% | +2.73% | +17.73% | +25.11% | 266B | |
| +0.58% | +6.76% | +10.58% | +17.75% | 259B | |
| +1.55% | +2.20% | +35.12% | +45.91% | 208B | |
| +0.79% | +1.84% | -27.55% | -56.48% | 191B | |
| -0.52% | +4.45% | +31.57% | +98.11% | 186B | |
| Average | +0.03% | +3.26% | +25.25% | +45.35% | 400.19B | |
| Weighted average by Cap. | -0.04% | +3.09% | +34.84% | +61.60% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 27.74M 19.81M 17.27M 16.31M 14.81M 1.9B 27.86M 195M 75.38M 966M 74.4M 72.75M 3.11B | 53.91M 38.48M 33.56M 31.69M 28.77M 3.69B 54.14M 380M 146M 1.88B 145M 141M 6.04B |
| Net income | -25.75M -18.38M -16.03M -15.13M -13.74M -1.76B -25.85M -181M -69.95M -897M -69.04M -67.51M -2.88B | -27.81M -19.85M -17.31M -16.34M -14.84M -1.9B -27.92M -196M -75.55M -968M -74.57M -72.91M -3.12B |
| Net Debt | 38.94M 27.8M 24.24M 22.89M 20.78M 2.67B 39.1M 274M 106M 1.36B 104M 102M 4.36B | 58.26M 41.59M 36.27M 34.24M 31.09M 3.99B 58.5M 410M 158M 2.03B 156M 153M 6.53B |
Employees
-
Sector
Pharmaceuticals
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- VPHIF Stock
- VPH Stock
Select your edition
All financial news and data tailored to specific country editions
